METACARE CO., Ltd. (KRX: 118000)

South Korea flag South Korea · Delayed Price · Currency is KRW
326.00
+13.00 (4.15%)
Nov 15, 2024, 3:30 PM KST
-19.11%
Market Cap 52.56B
Revenue (ttm) 56.97B
Net Income (ttm) -4.80B
Shares Out 164.78M
EPS (ttm) -36.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 91,373
Open 313.00
Previous Close 313.00
Day's Range 311.00 - 328.00
52-Week Range 305.00 - 684.00
Beta 1.17
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About METACARE CO.

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founded in 2009 and is headquartered in Hwaseong-si, South Korea. [Read more]

Sector Healthcare
Founded 2009
Employees 23
Stock Exchange Korea Stock Exchange
Ticker Symbol 118000
Full Company Profile

Financial Performance

In 2023, METACARE CO.'s revenue was 55.75 billion, an increase of 191.91% compared to the previous year's 19.10 billion. Losses were -14.54 billion, -70.66% less than in 2022.

Financial Statements

News

There is no news available yet.